Otsuka Holdings

Otsuka Files New Drug Application for Cholesterol Treatment in Japan

Zahra Ahangar Atashi - 28 November 2024

Otsuka Pharmaceutical Co., Ltd. has taken a significant step in addressing high cholesterol levels by submitting a New Drug Application (NDA) to Japan’s Ministry...

CMS

CMS Outlines Major Updates to Medicare Programs for 2026

Adam Marketaccess - 28 November 2024

The Centers for Medicare & Medicaid Services (CMS) has unveiled a comprehensive set of proposed changes for Contract Year 2026, aiming to enhance the...

Healthcare Policy and Regulation

Biden Proposal to Expand Medicare and Medicaid Coverage for Obesity Drugs

Elham Talatghoushchi - 26 November 2024

Key TakeawaysThe Biden administration proposes Medicare and Medicaid coverage for obesity drugs like Wegovy and Zepbound. The initiative could extend access to millions...

Clinical Researches

Otsuka Secures Global Licensing for FUS-ALS Treatment from Ionis

Adam Marketaccess - 23 November 2024

Otsuka Pharmaceutical Co., Ltd. has entered an exclusive worldwide licensing agreement with Ionis Pharmaceuticals to develop and market ulefnersen (ION363), a promising drug candidate...

Otsuka Holdings

Latest news

Orion Secures Sole European Rights for Shilpa’s Recombinant Human Serum Albumin

Ziftomenib Demonstrates Efficacy in AML Patients as Kura and Kyowa Showcase KOMET-001 Trial

Staff Vital in Enhancing Global Long-Term Care for Seniors

England’s NICE Endorses Sparsentan for Kidney Disease Treatment

Dedicated Pulmonary Care Shortens Hospital Stays and Boosts Follow-Up Rates

About Us

Popular Category